> Catalent has upped its stake in Redwood Bioscience, a company that provides technology for producing antibody-drug conjugates. More
> According to a Parexel ($PRXL) survey, Big Pharma sponsors prefer deep-seated partnerships to transactional relationships with CROs. Item